Novolin R 00169-3003
Generic: Human Insulin
Product NDC
00169-3003- Manufacturer
- Novo Nordisk
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Otc Drug
- Marketing Start
- September 6, 2019
- Listing Expires
- December 31, 2026
- Application
- BLA019938
Active Ingredients
| Ingredient | Strength |
|---|---|
| Insulin Human | 100 [iU]/mL |
Drug Class
Insulin [EPC]Insulin [CS]Insulin [EPC]
Packaging Options(2)
5 SYRINGE, PLASTIC in 1 CARTON (0169-3003-15) / 3 mL in 1 SYRINGE, PLASTIC (0169-3003-01)
5 SYRINGE, PLASTIC in 1 CARTON (0169-3003-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-3003-12)